EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature



Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature



Journal of Clinical Pharmacy and Therapeutics 37(3): 370-372



Aripiprazole has a low risk of extrapyramidal symptoms. Switching to aripiprazole has been reported to improve tardive dyskinesia caused by other medications. The authors report a case and review previous reports of dystonia and dyskinesia associated with aripiprazole. We present a case of a 22-year-old man with schizophrenia who experienced dyskinesia and dystonia associated with aripiprazole. Switching from olanzapine to aripiprazole resulted in worsening dyskinesia and new onset of dystonia. The patient's dyskinesia and dystonia improved after switching from aripiprazole to quetiapine therapy. There were several previous case reports on dyskinesia and dystonia associated with aripiprazole medication. The risk factors for tardive dyskinesia include older age and female sex. However, our case was a male patient who was younger compared with the previous cases and so should have been less at risk for dyskinesia in comparison with the previous cases. The effects of aripiprazole can include tardive movement disorders. Dyskinesia, dystonia and psychotic symptoms were improved with relatively small dose of quetiapine in this case. Whether some second-generation antipsychotics are more effective than others in the treatment of tardive dyskinesia remains unclear.

(PDF emailed within 0-6 h: $19.90)

Accession: 053749889

Download citation: RISBibTeXText

PMID: 22023382

DOI: 10.1111/j.1365-2710.2011.01290.x



Related references

Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report. Psychiatria Danubina 27(2): 195-197, 2015

Aripiprazole-induced tardive dyskinesia treated with quetiapine: a case report. Acta Neuropsychiatrica 23(4): 188-190, 2011

A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole. Primary Care Companion for Cns Disorders 13(6): -, 2011

Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment: a case report. Journal of Clinical Psychopharmacology 32(4): 563-564, 2012

Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data. Journal of Psychiatric Practice 22(3): 203-220, 2016

Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine. International Journal of Geriatric Psychiatry 20(3): 287-288, 2005

Duloxetine-related tardive dystonia and tardive dyskinesia: a case report. General Hospital Psychiatry 32(6): 646.E9-646.E11, 2011

Covert dyskinesia associated with aripiprazole: a case report and review of the literature. Clinical Neuropharmacology 36(4): 128-130, 2014

Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review. International Clinical Psychopharmacology 31(1): 57-60, 2016

Risperidone - induced tardive dyskinesia : case report and review of literature. Indian Journal of Psychiatry 43(1): 78-80, 2001

Quetiapine treatment of risperidone-related tardive dyskinesia. A case report. Actas Espanolas de Psiquiatria 31(5): 306-306, 2003

Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole. Primary Care Companion to the Journal of Clinical Psychiatry 7(1): 36-36, 2005

Olanzapine induced tardive dyskinesia treated successfully with quetiapine: a case report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35(1): 276-277, 2011

Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33(3): 571-572, 2009

Electroconvulsive therapy for a patient with persistent tardive dyskinesia: a case report and literature review. Journal of Ect 29(3): E52-E54, 2014